Health ProductsPublic Communication

Pulmicort Turbuhaler (budesonide) powder for oral inhalation - Potential device failure - For the Public

· Published by Health Canada · Official notice

Details

Alert type: Public Communication
Category: Drugs
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Introduction

This is duplicated text of a letter from AstraZeneca Canada Inc. Contact the company for a copy of any references, attachments or enclosures.

Notice about Health Canada advisories

Details

Public Communication - Health Canada Endorsed Important Safety Information on Pulmicort Turbuhaler (budesonide) powder for oral inhalation, 200 µg per metered dose

July 23, 2012

Subject: Potential device failure related to Pulmicort® Turbuhaler® (budesonide) powder for oral inhalation, 200 µg per metered dose (200 doses; DIN 00851752)

AstraZeneca Canada Inc., in consultation with Health Canada, would like to inform you of important information regarding complaints related to the asthma medication, Pulmicort® Turbuhaler® (budesonide) powder for oral inhalation, 200 µg per metered dose (200 doses). AstraZeneca Canada has received a small number of product complaints for Pulmicort Turbuhaler, 200 µg per metered dose (200 doses) related to the delivery device not working properly. Patients are advised that if they do not hear the 'click' sound when the 'turn grip' is rotated, the device is not working properly and they will not receive the dose of medication.

  • Complaints for Pulmicort Turbuhaler, 200 µg per metered dose (200 doses) have been received about the delivery device not working properly. Patients are advised that if they do not hear the "click" sound, the device is not working properly and they will not receive the dose of medication.
  • If a patient believes that their Pulmicort Turbuhaler is not working properly, they should contact their dispensing pharmacist or other health care professional. Additionally, they may contact AstraZeneca Medical Information at 1-800-668-6000 (English) and/or 1-800-461-3787 (French).
  • It is important for patients to understand the proper use of Pulmicort Turbuhaler (Turn, Click, Inhale), as described in the Consumer Information Leaflet.
  • In the Consumer Information Leaflet, patients are instructed to listen for the 'click' sound, as an indication that the inhaler has been loaded and is ready to use. A copy of the Consumer Information Leaflet can be found at: http://www.astrazeneca.ca/en/Our-Medicines/en-Products-AZ.

Pulmicort Turbuhaler is the brand name for the inhaled form of a drug called budesonide. Budesonide belongs to a group of medicines called corticosteroids which are used to reduce airway inflammation in patients with asthma. Turbuhaler is the brand name for a multiple-dose, dry powder inhaler. AstraZeneca is working to further investigate the complaints. This issue is specific to Pulmicort Turbuhaler, 200 µg per metered dose (200 doses).

Managing marketed health product-related adverse reactions depends on health care professionals and patients reporting them to the company or Health Canada. Therefore, the number of adverse reactions reported is generally believed to be less than those that actually occur. Any case of adverse reactions in patients receiving Pulmicort Turbuhaler should be reported to AstraZeneca Canada or Health Canada at the following addresses:

AstraZeneca Canada Inc.
1004 Middlegate Road
Mississauga, Ontario
Canada L4Y 1M4
Telephone: 1-877-404-8277

To report suspected adverse reactions to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or visit the MedEffect™ Canada Web site for information on how to report.

The Reporting Forms, postage paid labels, and Guidelines can be found on the MedEffect™ Canada Web site in the Adverse Reaction Reporting section.

For other health product inquiries related to this communication, please contact Health Canada at:
Health Products and Food Branch Inspectorate (HPFBI)
E-mail: DCVIU_UVECM@hc-sc.gc.ca
Telephone: 1-800-267-9675
Fax: 1-613-946-5636

Should you have any medical questions about Pulmicort Turbuhaler, feel free to contact AstraZeneca Medical Information at 1-800-668-6000 (English) and/or 1-800-461-3787 (French).

original signed by

Dr. Neil Maresky, M.B., B.Ch.
Vice President, Scientific Affairs
AstraZeneca Canada Inc.

Pulmicort®, Turbuhaler®, and the AstraZeneca logo are registered trademarks of the AstraZeneca group of companies.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime